Absci (ABSI)

• Market cap: $333M
• 1 day: 3.57%
• 5 days: 3.57%
• 1 month: -12.91%
• 3 months: -27.86%
• 6 months: -33.79%
• Year to date: 7.01%
• 1 year: -20.33%
• 5 years: -86.57%
• 10 years: -86.57%
• Sector: Industrials
• Industry: Commercial Physical & Biological Research

About: Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.

Employees: 156

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

427% more call options, than puts

Call options by funds: $1.98M | Put options by funds: $376K

88% more first-time investments, than exits

New positions opened: 30 | Existing positions closed: 16

32% more capital invested

Capital invested by funds: $210M [Q2] → $277M (+$67.2M) [Q3]

11% more funds holding

Funds holding: 110 [Q2] → 122 (+12) [Q3]

3.61% more ownership

Funds ownership: 60.18% [Q2] → 63.79% (+3.61%) [Q3]

0% more repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 33

Research analyst outlook

3 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $5 72% upside
• Avg. target: $7.33 153% upside
• High target: $10 245% upside

3 analyst ratings

• positive: 3 100%
• neutral: 0 0%
• negative: 0 0%

HC Wainwright & Co. Swayampakula Ramakanth 34% 1-year accuracy 63 / 188 met price target	141% upside $7	Buy Reiterated	17 Jan 2025
Keybanc Scott Schoenhaus 17% 1-year accuracy 6 / 36 met price target	72% upside $5	Overweight Maintained	8 Jan 2025
Guggenheim Vamil Divan 25% 1-year accuracy 5 / 20 met price target	245% upside $10	Buy Reiterated	3 Dec 2024